You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
The agreement takes aim at increasing adoption in Denmark and Sweden of Sienna's telomerase biomarker detection test, an aid in the diagnosis of bladder cancer.
Becton Dickinson and Euroclone aim to develop and commercialize the molecular assays for launch outside the US in 2018, and in the US at a later date.
Ampath will be one of the first laboratories in South Africa to offer a CE-IVD accredited noninvasive prenatal testing center and will act as a hub for such services.
The firm also inked a three-year distribution deal with Hitado to distribute the test, which is based on lateral flow technology, throughout Germany.
Diagenics will distribute in Great Britain and Ireland ProAxsis' immunoassay for measuring only the active form of neutrophil elastase.
GenomeDx will have exclusive rights to distribute the molecular tests in most of the US, while Pathnostics continues to perform the assays in-house.
Baebies said its deal with Labsystems enables it to provide a more comprehensive newborn screening offering to its customer base in global markets.
Asia Genomics will distribute NantHealth's cancer molecular profiling service in Singapore, Malaysia, Thailand, Vietnam, and the Philippines.
The deal will open up more opportunities to study OmniSeq's 144-gene NGS test and Immune Report Card in real-world settings and as part of drug development trials.
LabCorp will serve as exclusive distributor for OmniSeq's cancer assays and will participate in its Series B financing round.